Skip to main content
CDC logo

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$72.01 +$0.1516 (+0.21%)
Vol: 8.8K|

Beta 0.36: the stock has moved about 64% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) trades at $72.01. The VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) aims to mirror the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. Sector: Financials.

Price as of · Last analyzed: Mar 17, 2026
The VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) aims to mirror the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. It employs a volatility weighting methodology, adjusting equity exposure based on market conditions.

Analyst Coverage for CDC: CDC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the CDC film Every key number, told as a short cinematic story — just press play. ~2 min

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Financial Services Profile

IPO Year2014

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) offers investors exposure to a volatility-weighted portfolio of large-cap, high-dividend U.S. equities. The fund strategically adjusts its equity exposure based on market volatility, aiming to mitigate downside risk and enhance returns relative to traditional cap-weighted income strategies within the asset management sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for CDC?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The fund's volatility-weighted methodology aims to outperform traditional cap-weighted indices by tactically adjusting equity exposure based on market conditions. A key value driver is the fund's ability to mitigate downside risk during market downturns, potentially leading to superior long-term returns. The fund's success hinges on the effectiveness of the Long/Cash Index in identifying and reacting to market volatility. However, the absence of a dividend yield may deter some income-focused investors. The fund's performance will be closely tied to the performance of the Nasdaq Victory US Large Cap High Dividend 100 Volatility Weighted Index and its ability to navigate market fluctuations effectively.

Based on FMP financials and quantitative analysis

CDC Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Market Cap of $0.76 billion indicates a moderate-sized ETF with potential for growth and stability.

  • Beta of 0.36 suggests lower volatility compared to the broader market, appealing to risk-averse investors.
  • The fund's volatility weighting methodology aims to outperform traditional cap-weighted indices, potentially enhancing returns.
  • Tactical adjustments to equity exposure based on market conditions seek to mitigate downside risk during market downturns.
  • Absence of dividend yield may deter some income-focused investors, but the fund's focus is on total return through capital appreciation and risk management.

Who Are CDC's Competitors?

CDC is benchmarked below against 6 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
EWH iShares MSCI Hong Kong ETF $21.62 -0.69% $878M —
EWS iShares MSCI Singapore ETF $33.20 -0.18% $1.08B —
EWX State Street SPDR S&P Emerging Markets Small Cap ETF $72.09 +0.35% $780M —
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF $86.75 -0.79% $1.04B —
IYT iShares U.S. Transportation ETF $79.69 -0.20% $2.07B —
EICA Eagle Point Income Company Inc. $24.99 -0.04% $234M 36 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CDC's Key Strengths?

Unique volatility weighting methodology.

  • Lower beta compared to the broader market.
  • Potential for outperformance during market downturns.
  • Transparent and liquid investment vehicle.

What Are CDC's Weaknesses?

Absence of dividend yield may deter some investors.

  • Performance is dependent on the effectiveness of the Long/Cash Index.
  • May underperform during strong bull markets.
  • Relatively small market cap compared to larger ETF competitors.

What Are the Key Risks for CDC?

Underperformance during strong bull markets.

  • Changes in the Long/Cash Index methodology could impact performance.
  • Competition from other ETFs with similar investment strategies.
  • Economic downturn could lead to decreased AUM and lower management fees.

What Are CDC's Competitive Advantages?

  • Proprietary volatility weighting methodology provides a unique investment approach.
  • Established track record of managing risk and generating returns.
  • Strong brand reputation within the ETF market.
  • Experienced management team with expertise in asset allocation and risk management.

What Does CDC Do?

The VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) is designed to track the performance of the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. This index employs a unique strategy that combines fundamental criteria with volatility weighting, seeking to outperform conventional cap-weighted indexing approaches. The fund's core objective is to provide investors with a balance of income and capital appreciation, while also managing risk through tactical adjustments to equity exposure. The Long/Cash Index, which CDC aims to replicate, reduces its exposure to equity markets during periods of significant market decline and reinvests when market prices have further declined or rebounded. This methodology is based on the month-end price of the Nasdaq Victory US Large Cap High Dividend 100 Volatility Weighted Index relative to its All-Time Highest Daily Closing Value (AHDCV). The AHDCV represents the highest daily closing price the Reference Index has achieved since its inception. By dynamically adjusting its asset allocation, CDC aims to deliver enhanced risk-adjusted returns compared to traditional income-focused ETFs. The fund's investment strategy is particularly appealing to investors seeking to navigate volatile market environments while maintaining exposure to high-quality dividend-paying stocks.

What Products and Services Does CDC Offer?

  • Tracks the performance of the Nasdaq Victory US Large Cap High Dividend 100 Long/Cash Volatility Weighted Index.
  • Employs a volatility weighting methodology to enhance returns and mitigate risk.
  • Tactically reduces equity exposure during market declines and reinvests during rebounds.
  • Provides investors with exposure to a portfolio of large-cap, high-dividend U.S. equities.
  • Seeks to outperform traditional cap-weighted indexing strategies.
  • Offers a balance of income and capital appreciation.
  • Manages risk through dynamic asset allocation.

How Does CDC Make Money?

  • Generates revenue through management fees charged on assets under management (AUM).
  • AUM growth is driven by investment performance and net inflows from investors.
  • Expenses include operational costs, marketing expenses, and distribution fees.
  • Profitability depends on the ability to attract and retain assets while managing expenses effectively.

What Industry Does CDC Operate In?

The VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) operates within the asset management industry, specifically targeting income-seeking investors. The industry is characterized by a wide range of investment products, including ETFs, mutual funds, and separately managed accounts. The competitive landscape includes both large, established asset managers and smaller, specialized firms. CDC differentiates itself through its volatility-weighted methodology, which aims to provide downside protection during market downturns. The ETF market is experiencing growth, driven by increasing investor demand for low-cost, transparent investment vehicles. CDC's success will depend on its ability to attract and retain assets in a competitive environment.

Who Are CDC's Key Customers?

  • Retail investors seeking income and capital appreciation.
  • Financial advisors looking for risk-managed investment solutions.
  • Institutional investors seeking to diversify their portfolios.
  • Retirement savers seeking long-term growth and income.
Model self-rating on this text: 73% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is an etf, not an operating company

MoonshotScore History

Recorded daily since 2026-08-23 · 42 snapshots

2026-08-23 47
2026-08-31 47
2026-09-08 47
2026-09-16 47
2026-09-24 47
2026-10-04 47
2026-10-05 47

What changed?

The score has stayed at 47.

Over the same 30 days the stock moved -6.5%.

CDC Financials

Bull Case vs Bear Case

Bull Case

  • Unique volatility weighting methodology.
  • Lower beta compared to the broader market.
  • Potential for outperformance during market downturns.
  • Transparent and liquid investment vehicle.

Bear Case

  • Absence of dividend yield may deter some investors.
  • Performance is dependent on the effectiveness of the Long/Cash Index.
  • May underperform during strong bull markets.
  • Relatively small market cap compared to larger ETF competitors.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

CDC Latest News

No recent news available for CDC.

CDC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CDC.

Price Targets

Wall Street price target analysis for CDC.

CDC MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CDC; grades run from A+ (80-100) to F (below 30).

CDC Financials Stock FAQ

What are the main risks for CDC?

The main risks for CDC include the potential for underperformance during strong bull markets, as the fund's volatility-weighting methodology may limit its upside participation. Changes in the Long/Cash Index methodology could also impact performance. Competition from other ETFs with similar investment strategies is an ongoing risk. An economic downturn could lead to decreased AUM and lower management fees.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and is subject to change.
  • Investors should consult with a financial advisor before making any investment decisions.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis